Related references
Note: Only part of the references are listed.Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
Kayvon Modjarrad et al.
LANCET INFECTIOUS DISEASES (2019)
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
Zhiqi Song et al.
VIRUSES-BASEL (2019)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease
Patricio L. Acosta et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
Evaluation of candidate vaccine approaches for MERS-CoV
Lingshu Wang et al.
NATURE COMMUNICATIONS (2015)
Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology
Yoshikazu Honda-Okubo et al.
JOURNAL OF VIROLOGY (2015)
Effects of Toll-Like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-Related Coronavirus Vaccine
Naoko Iwata-Yoshikawa et al.
JOURNAL OF VIROLOGY (2014)
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Chien-Te Tseng et al.
PLOS ONE (2012)
Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH-and Cysteine Protease-Independent FcγR Pathway
Martial Jaume et al.
JOURNAL OF VIROLOGY (2011)
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response
Meagan Bolles et al.
JOURNAL OF VIROLOGY (2011)
Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
Fumihiko Yasui et al.
JOURNAL OF IMMUNOLOGY (2008)
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
Julie E. Martin et al.
VACCINE (2008)
Share Paper
